Eight undescribed metabolites (1-8), including three sesquiterpenoids (1-3) and five 2-(2-phenylethyl)chromones (4-8), and 28 known compounds (8-35) were isolated by bioassay-guided fractionation of A. sinensis extract. Their structures were elucidated by analyses of NMR and MS data, as well as single-crystal X-ray diffraction and ECD calculations. All the isolated compounds were systematically evaluated cytotoxic and anti-inflammatory activity. Four compounds including one eudesmane-type sesquiterpenoid (-)-(5R,7R,10R)-12,15-dioxo-α-selinene (9) and three 5,6:7,8-diepoxy-2-(2-phenylethyl)-5,6,7,8-tetrahydrochromones, namely (5R,6R,7R,8R)-oxidoagarochromone A (11), (5S,6S,7S,8S)-oxidoagarochromone B (12), and (5S,6S,7S,8S)-oxidoagarochromone C (13), were the most cytotoxic against eleven cancer cell lines (HL-60, K562, A549, MDA-MB-231, SW480, HepG2, HCT116, Caco2, SK-OV-3, MG-63, and U251), with IC50 values of 0.18-6.35 μM. Moreover, compounds 9 (IC50 = 0.19 μM), 11 (IC50 = 0.60 μM), and 12 (IC50 = 1.01 μM), and (5R,6S,7S,8S)-7,8-dihydroxy-5,6-epoxy-2-[2-(4-methoxyphenyl)ethyl]-5,6,7,8-tetrahydrochrome (16; IC50 = 3.55 μM) exhibited the strongest inhibition of the NO production. The absolute configurations of compounds 11-13 were determined by X-ray diffraction for the first time. These dual anticancer/anti-inflammatory compounds (9, 11, and 12) may serve as promising candidates for future mechanistic and in vivo studies.